GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
12.2004 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
11.2581 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, AKR1B1, ALOX15, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, EGFR, F10, FLT3, GPR35, HCAR2, HSPA1A, HTR2C, INSR, KDR, MET, MMP12, MMP9, PIK3CA, PIK3CB, PPARD, PTGS2, SMAD3, SRC, TEK, XDH |
10.628 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, AKR1B1, ALOX15, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, EGFR, F10, FLT3, GPR35, HCAR2, HSPA1A, HTR2C, INSR, KDR, MET, MMP12, MMP9, PIK3CA, PIK3CB, PPARD, PTGS2, SMAD3, SRC, TEK, XDH |
10.628 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADORA1, AKR1B1, ALOX15, CA12, CA2, CA7, CHRM1, CNR1, CNR2, CYP19A1, CYP1A1, CYP1B1, EGFR, ESR1, F10, FABP3, FABP4, FLT3, GPR35, HCAR2, HSD17B1, HSPA1A, HTR2C, INSR, KDR, MET, PIK3CA, PIK3CB, PPARA, PPARD, PTGS1, PTGS2, SMAD3, SRC, TEK, XDH |
10.2897 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, ALOX15, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EGFR, ESR1, FABP3, FABP4, FUT7, HSD17B1, MET, PIK3CA, PIK3CB, PPARA, PPARD, PTGS1, PTGS2 |
10.0653 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, ALOX15, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, FUT7, HSPA1A, HTR2C, PIK3CA, PPARA, PPARD, PTGS1, PTGS2, XDH |
9.51027 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, AKR1B1, ALOX15, CA2, CA7, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, ESR1, F10, FLT3, GPR35, HCAR2, HSPA1A, HTR2C, IGF1R, INSR, KDR, MET, MMP12, MMP9, NUAK1, PIK3CA, PIK3CB, PPARD, PTGS2, SMAD3, SRC, TEK, XDH |
8.64595 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, AKR1B1, ALOX15, CA2, CA7, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, ESR1, F10, FLT3, GPR35, HCAR2, HSPA1A, HTR2C, IGF1R, INSR, KDR, MET, MMP12, MMP9, NUAK1, PIK3CA, PIK3CB, PPARD, PTGS2, SMAD3, SRC, TEK, XDH |
8.54677 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, AKR1B1, CHRM1, CSNK2A1, CYP1B1, EGFR, ESR1, FABP3, FLT3, HSPA1A, IGF1R, INSR, KDR, MMP12, MMP2, MMP9, NUAK1, PPARD, PTGS1, PTGS2, SMAD3, SRC, TEK, XDH |
8.31246 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
ALOX15, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, PTGS1, PTGS2 |
8.22117 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, AKR1B1, ALOX15, CSNK2A1, CYP1B1, DUSP3, EGFR, ESR1, F10, FLT3, GPR35, HSPA1A, HTR2C, IGF1R, INSR, KDR, MET, MMP9, NUAK1, PIK3CA, PIK3CB, PPARD, PTGS2, SRC, TEK, XDH |
8.21124 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, AKR1B1, ALOX15, CSNK2A1, CYP1B1, EGFR, F10, FLT3, GPR35, HSPA1A, HTR2C, INSR, KDR, MET, MMP12, MMP9, PIK3CA, PIK3CB, PPARD, PTGS2, SMAD3, SRC, TEK, XDH |
8.20628 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, AKR1B1, ALOX15, CYP1B1, EGFR, F10, FLT3, GPR35, HSPA1A, HTR2C, INSR, KDR, MET, PIK3CA, PIK3CB, PPARD, PTGS2, SRC, TEK, XDH |
8.20628 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, ALOX15, CA2, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, FABP3, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MMP2, PIK3CA, PPARA, PPARD, PTGS2, SMAD3, SRC, TEK |
8.20628 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, ALOX15, CA2, CA7, CHRM1, CNR1, CSNK2A1, CYP19A1, CYP1B1, EGFR, F10, GPR35, HCAR2, HSPA1A, HTR2C, IGF1R, INSR, KDR, MET, MMP12, MMP9, PIK3CB, PPARA, PPARD, PTGS2, SMAD3, SRC, TEK |
7.77622 |
[BP] GO:0042221 |
response to chemical
|
AKR1B1, ALOX15, CA2, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, FABP3, FABP4, FLT3, HSPA1A, HTR2C, IGF1R, INSR, KDR, MMP2, MMP9, PIK3CA, PPARA, PPARD, PTGS2, SMAD3, SRC, TEK |
7.65998 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, AKR1B1, ALOX15, CNR1, CSNK2A1, CYP1B1, EGFR, F10, FABP4, FLT3, GPR35, HSPA1A, HTR2C, INSR, KDR, MET, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PPARD, PTGS2, SMAD3, SRC, TEK, XDH |
7.41515 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, ALOX15, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EGFR, FABP3, FABP4, FUT7, MET, PIK3CA, PIK3CB, PPARA, PPARD, PTGS1, PTGS2 |
7.41515 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, FABP3, IGF1R, INSR, MMP2, MMP9, PIK3CA, PPARA, PPARD, PTGS2, SRC, TEK |
7.08872 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, CHRM1, CHRM4, CYP19A1, CYP1B1, EGFR, F10, IGF1R, INSR, KDR, MET, MMP9, PPARD, PTGS2, SMAD3, SRC, TEK |
7.06037 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, AKR1B1, ALOX15, CA2, CA7, CHRM1, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DUSP3, EGFR, ESR1, F10, FABP3, FLT3, GPR35, HCAR2, HSPA1A, HTR2C, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, PPARD, PTGS2, SMAD3, SRC, TEK, XDH |
6.84144 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, CNR1, CSNK2A1, CYP1B1, EGFR, ESR1, FLT3, HCAR2, HSPA1A, IGF1R, KDR, MET, MMP9, PIK3CA, PIK3CB, PPARA, PPARD, PTGS2, SMAD3, SRC, TEK, XDH |
6.83467 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, CNR1, CSNK2A1, CYP1B1, EGFR, ESR1, FLT3, HCAR2, HSPA1A, IGF1R, KDR, MET, MMP9, PIK3CA, PIK3CB, PPARD, PTGS2, SMAD3, SRC, TEK, XDH |
6.65488 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, FABP3, PPARA, PPARD |
6.62792 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX15, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, PTGS1, PTGS2 |
6.44779 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
ALOX15, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, PTGS1, PTGS2 |
6.35241 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, CYP19A1, CYP1B1, EGFR, F10, IGF1R, INSR, KDR, MET, MMP9, PPARD, PTGS2, SMAD3, SRC, TEK |
6.24757 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX15, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, PTGS1, PTGS2 |
6.24757 |
[BP] GO:0080134 |
regulation of response to stress
|
ADORA1, CNR1, CNR2, CYP19A1, DUSP3, EGFR, ESR1, FABP4, HSPA1A, IGF1R, MET, MMP12, MMP2, NUAK1, PPARA, PPARD, PTGS2, SMAD3, SRC, TEK, XDH |
6.21968 |
[BP] GO:0031347 |
regulation of defense response
|
ADORA1, CNR1, CNR2, CYP19A1, EGFR, ESR1, FABP4, HSPA1A, MMP12, MMP2, PPARA, PPARD, PTGS2, SMAD3, SRC, TEK |
6.14849 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX15, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, PPARA, PPARD, PTGS1, PTGS2 |
6.11124 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADORA1, AKR1B1, ALOX15, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, ESR1, F10, FABP4, FLT3, GPR35, HSPA1A, HTR2C, IGF1R, INSR, KDR, MET, MMP12, MMP2, MMP9, NUAK1, PIK3CA, PIK3CB, PPARA, PPARD, PTGS2, SMAD3, SRC, TEK, XDH |
6.08592 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA1, ADORA3, AKR1B1, ALOX15, CA2, CA6, CA9, CHRM2, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, F10, FABP3, FABP4, FLT3, HSPA1A, HTR2C, IGF1R, INSR, KDR, MMP12, MMP2, MMP9, NUAK1, PIK3CA, PIK3CB, PPARA, PPARD, PTGS1, PTGS2, SMAD3, SRC, TEK |
6.07166 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, CNR1, CSNK2A1, CYP1B1, EGFR, ESR1, FLT3, HCAR2, HSPA1A, IGF1R, KDR, MMP9, PIK3CA, PIK3CB, PPARD, PTGS2, SMAD3, SRC, TEK, XDH |
6.0406 |
[BP] GO:0050727 |
regulation of inflammatory response
|
ADORA1, CNR1, CNR2, CYP19A1, EGFR, ESR1, FABP4, PPARA, PPARD, PTGS2, SMAD3, TEK |
6.0221 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, CYP19A1, CYP1B1, EGFR, F10, IGF1R, INSR, KDR, MET, MMP9, PPARD, PTGS2, SMAD3, SRC, TEK |
5.93435 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, AKR1B1, ALOX15, CA2, CA7, CHRM1, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DUSP3, EGFR, ESR1, F10, FABP3, FABP4, FLT3, GPR35, HCAR2, HSPA1A, HTR2C, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, PPARD, PTGS2, SMAD3, SRC, TEK, XDH |
5.9071 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, AKR1B1, CNR1, CYP19A1, CYP1A1, CYP1B1, EGFR, ESR1, HCAR2, HSD17B1, HTR2C, PPARD |
5.76001 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, CA2, CA9, CSNK2A1, CYP1A2, EGFR, ESR1, FABP3, FLT3, IGF1R, INSR, MMP2, PPARA, PTGS2, SMAD3, SRC, TEK |
5.73332 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
5.73106 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, ALOX15, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CHRM1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DUSP3, EGFR, ESR1, F10, FABP3, FABP4, FLT3, FUT7, HSD17B1, HSPA1A, HTR2C, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NQO2, NUAK1, PIK3CA, PIK3CB, PPARA, PPARD, PTGS1, PTGS2, SMAD3, SRC, TEK, XDH |
5.65781 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, CYP19A1, CYP1B1, EGFR, F10, IGF1R, INSR, KDR, MET, MMP9, PPARD, PTGS2, SMAD3, SRC, TEK |
5.48747 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, FABP3, PPARA, PPARD |
5.45964 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALOX15, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP9, PIK3CA, PPARD, PTGS2, SMAD3, SRC |
5.44261 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, ALOX15, CNR1, CNR2, CYP19A1, DUSP3, EGFR, ESR1, HSPA1A, IGF1R, MET, MMP12, MMP9, PPARA, PPARD, PTGS2, SMAD3, SRC, TEK, XDH |
5.44261 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, CA2, CA9, CSNK2A1, CYP1A2, EGFR, ESR1, FABP3, FLT3, INSR, PPARA, PTGS2, SRC, TEK |
5.44214 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
5.41793 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, CNR1, CNR2, CYP19A1, EGFR, ESR1, FABP4, KDR, MET, MMP12, PPARA, PPARD, PTGS2, SMAD3, TEK |
5.41395 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, CNR1, CYP1A1, FABP3, FLT3, HCAR2, HTR2C, PPARA, PTGS2, SRC, TEK |
5.35603 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, AKR1B1, CA12, CA2, CA7, CNR1, EGFR, ESR1, FABP3, FABP4, FLT3, GPR35, HTR2C, INSR, MET, PIK3CA, PIK3CB, SMAD3, SRC |
5.32385 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADORA1, ALOX15, CA2, CA7, CHRM1, CNR1, CYP19A1, EGFR, GPR35, HCAR2, HSPA1A, HTR2C, INSR, MMP12, MMP9, PIK3CB, PPARA, PPARD, PTGS2, SMAD3, SRC |
5.32385 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, ALOX15, CA2, CYP1A1, CYP1A2, CYP1B1, EGFR, FABP4, KDR, MMP9, PTGS2, SRC |
5.32385 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
EGFR, F10, INSR, MET, PIK3CA, PIK3CB, SRC, TEK, XDH |
5.27567 |
[BP] GO:0048878 |
chemical homeostasis
|
AKR1B1, CA12, CA2, CA7, CNR1, EGFR, ESR1, FABP3, FABP4, GPR35, HTR2C, INSR, MET, PIK3CA, PIK3CB, SMAD3 |
5.22942 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, CSNK2A1, EGFR, HSPA1A, IGF1R, KDR, MET, MMP9, PIK3CA, PPARA, PPARD, PTGS2, SMAD3, SRC, TEK |
5.20842 |
[BP] GO:0051897 |
positive regulation of protein kinase B signaling
|
EGFR, F10, INSR, MET, PIK3CA, PIK3CB, SRC, TEK |
5.19822 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, AKR1B1, ALOX15, CSNK2A1, CYP1B1, DUSP3, EGFR, ESR1, F10, FLT3, GPR35, HSPA1A, HTR2C, IGF1R, INSR, KDR, MET, MMP12, MMP9, NUAK1, PIK3CA, PIK3CB, PPARD, PTGS2, SMAD3, SRC, TEK, XDH |
5.16903 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, ALOX15, DUSP3, EGFR, FABP3, FABP4, FLT3, HTR2C, IGF1R, INSR, KDR, MMP9, NUAK1, PIK3CA, PIK3CB, PPARA, PTGS2, SMAD3, SRC, TEK, XDH |
5.15952 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX15, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, PTGS1, PTGS2 |
5.15952 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, ALOX15, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CHRM1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DUSP3, EGFR, ESR1, F10, FABP3, FABP4, FLT3, FUT7, HSD17B1, HSPA1A, HTR2C, IGF1R, INSR, KDR, MET, MMP1, MMP2, NQO2, NUAK1, PIK3CA, PIK3CB, PPARA, PPARD, PTGS1, PTGS2, SMAD3, SRC, TEK, XDH |
5.1537 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, ALOX15, DUSP3, EGFR, FABP3, FABP4, FLT3, HTR2C, IGF1R, INSR, KDR, MMP9, NUAK1, PIK3CA, PIK3CB, PPARA, PTGS2, SMAD3, SRC, TEK, XDH |
5.12005 |
[BP] GO:0033993 |
response to lipid
|
CA2, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, EGFR, ESR1, FABP3, FLT3, PPARD, PTGS2, SRC |
5.08262 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
EGFR, FLT3, IGF1R, INSR, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, SRC, TEK |
5.05585 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, CSNK2A1, EGFR, HSPA1A, IGF1R, KDR, MET, MMP9, PIK3CA, PPARD, PTGS2, SMAD3, SRC, TEK |
4.953 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADORA1, CA2, CA7, CNR1, CNR2 |
4.953 |
[BP] GO:0031348 |
negative regulation of defense response
|
ADORA1, CNR2, CYP19A1, MMP12, PPARA, PPARD, SMAD3, TEK |
4.87788 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, CHRM1, CSNK2A1, EGFR, ESR1, FLT3, IGF1R, INSR, KDR, MMP12, MMP2, MMP9, PPARD, PTGS2, TEK |
4.86239 |
[BP] GO:0050728 |
negative regulation of inflammatory response
|
ADORA1, CNR2, CYP19A1, PPARA, PPARD, SMAD3, TEK |
4.81428 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, ESR1, HSD17B1, PPARD |
4.81428 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, AKR1B1, ALOX15, CHRM1, CNR1, CNR2, CYP19A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, F10, FABP4, HTR2C, IGF1R, INSR, MET, MMP1, MMP12, MMP2, MMP9, PIK3CA, PPARA, PPARD, PTGS2, SMAD3, SRC, TEK |
4.81016 |
[BP] GO:0048513 |
animal organ development
|
ACHE, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, EGFR, ESR1, FLT3, INSR, KDR, PIK3CA, PPARA, PPARD, SMAD3, SRC, TEK |
4.77971 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, ALOX15, CYP1A1, EGFR, PPARA, PPARD, SMAD3 |
4.75183 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, CYP1A1, MMP2, PPARA, PPARD, PTGS2, SMAD3, SRC, TEK |
4.66471 |
[BP] GO:0030335 |
positive regulation of cell migration
|
EGFR, F10, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK |
4.66471 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, HTR2C, PPARA, PTGS2, SRC, TEK |
4.64985 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALOX15, CYP1A1, CYP1B1, EGFR, ESR1, FABP4, FLT3, IGF1R, INSR, KDR, MMP2, PIK3CA, PPARD, PTGS2, SMAD3, SRC |
4.64985 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
4.64929 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, ALOX15, CSNK2A1, CYP19A1, CYP1A1, HSD17B1, PIK3CA, PIK3CB, PPARD, PTGS1, PTGS2 |
4.64699 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
EGFR, FLT3, IGF1R, INSR, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, SMAD3, SRC, TEK |
4.6133 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
4.60824 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, CYP1A1, MMP2, PPARA, PPARD, PTGS2, SMAD3, SRC, TEK |
4.58215 |
[BP] GO:2000147 |
positive regulation of cell motility
|
EGFR, F10, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK |
4.54275 |
[BP] GO:0046777 |
protein autophosphorylation
|
CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, SRC, TEK |
4.50685 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, ALOX15, EGFR, FABP3, FLT3, HTR2C, INSR, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, SMAD3, SRC, TEK, XDH |
4.50471 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, ALOX15, EGFR, FABP3, FLT3, HTR2C, INSR, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, SMAD3, SRC, TEK, XDH |
4.50471 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
EGFR, F10, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK |
4.44439 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA1, ADORA3, AKR1B1, ALOX15, CA2, CA9, CNR2, CYP1A1, CYP1A2, CYP1B1, EGFR, HSPA1A, HTR2C, MMP2, MMP9, NUAK1, PIK3CA, PIK3CB, PPARA, PPARD, PTGS1, PTGS2, SMAD3, SRC, TEK |
4.42251 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, CA2, CA7, CNR1, EGFR, HCAR2, HTR2C, KDR, PIK3CB, PTGS2, SRC |
4.41521 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, HTR2C, SRC, TEK |
4.39885 |
[BP] GO:0032787 |
None
|
ALOX15, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, PPARA, PPARD, PTGS1, PTGS2 |
4.38992 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, ALOX15, DUSP3, EGFR, FLT3, HTR2C, IGF1R, INSR, KDR, PIK3CB, SRC, TEK, XDH |
4.35597 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, CSNK2A1, EGFR, HSPA1A, IGF1R, KDR, MMP9, PIK3CA, PPARD, PTGS2, SMAD3, SRC, TEK |
4.32717 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, CYP1A1, MMP2, PPARA, PPARD, PTGS2, SMAD3, SRC, TEK |
4.32717 |
[BP] GO:0040017 |
positive regulation of locomotion
|
EGFR, F10, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK |
4.32717 |
[BP] GO:0014070 |
response to organic cyclic compound
|
CA2, CA9, CNR1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, FLT3, PTGS2, SRC, TEK |
4.32223 |
[BP] GO:0007197 |
None
|
CHRM1, CHRM2, CHRM4 |
4.31643 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, FABP3, FABP4, FUT7, HSPA1A, MMP1, MMP12, MMP2, MMP9, PIK3CB, PPARD, SRC, XDH |
4.25608 |
[BP] GO:0038083 |
peptidyl-tyrosine autophosphorylation
|
EGFR, IGF1R, INSR, KDR, SRC |
4.24969 |
[BP] GO:0071248 |
cellular response to metal ion
|
ALOX15, CYP1A1, CYP1A2, EGFR, FABP4, MMP9, PTGS2 |
4.21478 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, ALOX15, DUSP3, EGFR, FABP4, FLT3, HTR2C, IGF1R, INSR, KDR, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, SRC, TEK, XDH |
4.17563 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, ALOX15, EGFR, FLT3, HTR2C, INSR, KDR, PIK3CB, SRC, TEK, XDH |
4.16221 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, CA2, CHRM1, CHRM2, CNR1, CYP1B1, EGFR, ESR1, GPR35, HCAR2, HSPA1A, HTR2C, INSR, KDR, MET, MMP12, MMP9, PIK3CA, PPARD, PTGS2, SMAD3, SRC, TEK, XDH |
4.14632 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, ALOX15, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, HSD17B1, NQO2, PPARD, PTGS1, PTGS2, XDH |
4.12942 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, CNR1, CNR2, EGFR, FABP3, FLT3, IGF1R, INSR, MMP2, PPARA, PTGS2, SRC, TEK |
4.12942 |
[BP] GO:0003018 |
None
|
ADORA1, CHRM1, EGFR, PPARD, PTGS2, SRC, TEK |
4.10464 |
[BP] GO:0007207 |
None
|
CHRM1, CHRM2, CHRM4 |
4.06144 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, AKR1B1, ALOX15, CA2, CA9, CHRM1, CHRM2, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, FABP4, FLT3, FUT7, INSR, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, PPARD, PTGS2, SMAD3, SRC, TEK |
4.05317 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, ALOX15, DUSP3, EGFR, FABP4, FLT3, HTR2C, IGF1R, INSR, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, SRC, TEK, XDH |
4.02543 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, CNR1, CNR2, CSNK2A1, DUSP3, EGFR, ESR1, FABP4, FLT3, HSPA1A, IGF1R, INSR, MMP9, NUAK1, PIK3CA, PIK3CB, PTGS2, SMAD3, SRC, TEK, XDH |
4.00774 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, CHRM1, CHRM4, CYP1A1, EGFR, ESR1, FLT3, MET, PIK3CB, PPARD, SRC, TEK |
4.00774 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, ALOX15, EGFR, FLT3, HTR2C, INSR, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, SRC, TEK, XDH |
3.87148 |
[BP] GO:0031399 |
regulation of protein modification process
|
ADORA1, ALOX15, DUSP3, EGFR, FABP4, FLT3, HSPA1A, HTR2C, IGF1R, INSR, KDR, MMP9, NUAK1, PIK3CA, PIK3CB, PTGS2, SRC, TEK, XDH |
3.86382 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALOX15, CSNK2A1, DUSP3, EGFR, FLT3, HSPA1A, HTR2C, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIK3CB, PPARD, PTGS2, SRC, TEK, XDH |
3.85049 |
[BP] GO:0009698 |
phenylpropanoid metabolic process
|
CYP1A1, CYP2A13, CYP2A6 |
3.84834 |
[BP] GO:0009804 |
coumarin metabolic process
|
CYP1A1, CYP2A13, CYP2A6 |
3.84834 |
[BP] GO:0090087 |
None
|
ACHE, ADORA1, CA2, CHRM1, CNR1, EGFR, HCAR2, HTR2C, MMP12, PPARD, PTGS2, SMAD3, SRC |
3.84834 |
[BP] GO:0071241 |
cellular response to inorganic substance
|
ALOX15, CYP1A1, CYP1A2, EGFR, FABP4, MMP9, PTGS2 |
3.83827 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1 |
3.83231 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, AKR1B1, ALOX15, CA2, CHRM1, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, FLT3, INSR, KDR, MMP9, PIK3CA, PPARA, PPARD, PTGS2, SMAD3, SRC, TEK |
3.82734 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, CNR1, CNR2, EGFR, FABP3, FLT3, IGF1R, INSR, MMP2, PPARA, PTGS2, SRC, TEK |
3.80619 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADORA1, ALOX15, CSNK2A1, EGFR, ESR1, FLT3, HSPA1A, HTR2C, INSR, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, SMAD3, SRC, TEK, XDH |
3.78026 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, CNR2, DUSP3, EGFR, ESR1, GPR35, HSPA1A, IGF1R, MET, MMP12, MMP9, PTGS2, SMAD3, SRC, XDH |
3.76226 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, CNR2, DUSP3, EGFR, ESR1, GPR35, HSPA1A, IGF1R, MET, MMP12, MMP9, PTGS2, SMAD3, SRC, XDH |
3.74724 |
[BP] GO:0007186 |
G-protein coupled receptor signaling pathway
|
ADORA1, ADORA3, CA2, CHRM1, CHRM2, CHRM4, CNR1, CNR2, ESR1, GPR35, HCAR2, HTR2C, INSR, PIK3CA, PIK3CB, SRC |
3.74553 |
[BP] GO:0016477 |
cell migration
|
CNR2, CYP1B1, EGFR, FUT7, KDR, MMP1, MMP12, MMP9, PIK3CA, PIK3CB, PPARD, SRC, TEK |
3.74081 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, NQO2, PTGS1 |
3.71905 |
[BP] GO:0009895 |
negative regulation of catabolic process
|
ADORA1, CNR1, EGFR, HCAR2, MET, PIK3CA, PPARA, SMAD3 |
3.71122 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, ALOX15, EGFR, FLT3, HTR2C, INSR, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, SRC, TEK, XDH |
3.69611 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, ALOX15, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP9, NUAK1, PIK3CA, PPARD, PTGS2, SMAD3, SRC |
3.66954 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1 |
3.66716 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALOX15, CSNK2A1, DUSP3, EGFR, FLT3, HSPA1A, HTR2C, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIK3CB, PPARD, PTGS2, SRC, TEK, XDH |
3.59497 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, CNR1, CNR2, CSNK2A1, CYP1B1, DUSP3, ESR1, FABP4, GPR35, IGF1R, MET, MMP9, PPARA, PTGS2, SRC |
3.59497 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, CA9, CNR1, CNR2, CYP1A1, CYP1B1, EGFR, FABP3, HTR2C, KDR, PTGS2, SRC |
3.54297 |
[BP] GO:0040011 |
locomotion
|
CNR2, CYP1B1, EGFR, FUT7, KDR, MET, MMP1, MMP12, MMP9, PIK3CA, PIK3CB, PPARD, SRC, TEK |
3.53699 |
[BP] GO:0010634 |
positive regulation of epithelial cell migration
|
KDR, MET, MMP9, PTGS2, SRC, TEK |
3.5169 |
[BP] GO:0065009 |
regulation of molecular function
|
ADORA1, ADORA3, CNR1, CNR2, CSNK2A1, CYP1B1, DUSP3, EGFR, ESR1, FABP4, FLT3, GPR35, HSPA1A, IGF1R, INSR, MET, MMP9, NUAK1, PIK3CA, PIK3CB, PPARA, PTGS2, SMAD3, SRC, TEK, XDH |
3.5169 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ADORA1, ALOX15, EGFR, ESR1, FLT3, HSPA1A, HTR2C, INSR, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, SMAD3, SRC, TEK, XDH |
3.48868 |
[BP] GO:0048660 |
regulation of smooth muscle cell proliferation
|
AKR1B1, EGFR, MMP2, MMP9, PPARD, PTGS2 |
3.46359 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, CYP1B1, EGFR, ESR1, IGF1R, INSR, MMP2, MMP9, PIK3CA, PPARD, PTGS2, SRC |
3.4534 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
FABP3, FLT3, HTR2C, SRC, TEK |
3.4534 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, AKR1B1, CA1, CA2, CHRM1, CHRM2, CHRM4, CNR1, CNR2, CSNK2A1, CYP1B1, EGFR, ESR1, FLT3, GPR35, HCAR2, HTR2C, IGF1R, INSR, KDR, MET, MMP2, MMP9, NUAK1, PIK3CA, PIK3CB, PPARA, PPARD, SMAD3, SRC, TEK |
3.4366 |
[BP] GO:0003013 |
None
|
ADORA1, CHRM1, EGFR, PPARD, PTGS2, SRC, TEK |
3.40583 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.3973 |
[BP] GO:0009894 |
regulation of catabolic process
|
ADORA1, CNR1, CSNK2A1, EGFR, HCAR2, HSPA1A, INSR, KDR, MET, PIK3CA, PIK3CB, PPARA, SMAD3 |
3.3606 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, EGFR, MMP2, MMP9, PTGS2 |
3.35105 |
[BP] GO:0048870 |
cell motility
|
CNR2, CYP1B1, EGFR, FUT7, KDR, MMP1, MMP12, MMP9, PIK3CA, PIK3CB, PPARD, SRC, TEK |
3.34976 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, CA2, CA7, CNR1, CNR2, EGFR, PTGS2 |
3.33671 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, CA2, CA7, CNR1, CNR2, EGFR, PTGS2 |
3.33671 |
[BP] GO:0046486 |
glycerolipid metabolic process
|
ACHE, ALOX15, CSNK2A1, EGFR, FABP3, FABP4, MET, PIK3CA, PIK3CB |
3.33671 |
[BP] GO:0044057 |
None
|
ADORA1, ADORA3, CHRM1, CHRM2, EGFR, GPR35, HCAR2, HTR2C, PTGS2, SMAD3 |
3.33671 |
[BP] GO:0042060 |
None
|
ALOX15, EGFR, PPARA, PPARD, SMAD3 |
3.33671 |
[BP] GO:0007566 |
embryo implantation
|
MMP2, MMP9, PPARD, PTGS2 |
3.19785 |
[BP] GO:0030155 |
regulation of cell adhesion
|
ALOX15, CYP1B1, DUSP3, KDR, NUAK1, PIK3CA, PIK3CB, PPARA, SMAD3, SRC, TEK |
3.18998 |
[BP] GO:0045759 |
None
|
CNR1, CNR2, GPR35 |
3.17435 |
[BP] GO:0010038 |
response to metal ion
|
ALOX15, CA2, CYP1A1, CYP1A2, EGFR, FABP4, MMP9, PTGS2 |
3.17435 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
CA2, CA7, CNR1, EGFR, HCAR2, PIK3CB, PTGS2 |
3.17021 |
[BP] GO:0051050 |
positive regulation of transport
|
ACHE, ADORA1, CA2, CHRM1, CYP19A1, EGFR, HCAR2, INSR, MMP12, PPARD, PTGS2, SMAD3, SRC |
3.15275 |
[BP] GO:0008217 |
None
|
ADORA1, CNR1, PPARA, PTGS1, PTGS2, SMAD3 |
3.13931 |
[BP] GO:0009987 |
cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, ALOX15, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CHRM1, CHRM2, CHRM4, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DUSP3, EGFR, ESR1, F10, FABP3, FABP4, FLT3, FUT7, GPR35, HCAR2, HSD17B1, HSPA1A, HTR2C, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NQO2, NUAK1, PIK3CA, PIK3CB, PPARA, PPARD, PTGS1, PTGS2, SMAD3, SRC, TEK, XDH |
3.13268 |
[BP] GO:0007200 |
None
|
CHRM1, CHRM2, CHRM4, ESR1, HTR2C |
3.10359 |
[BP] GO:1904407 |
positive regulation of nitric oxide metabolic process
|
EGFR, INSR, PTGS2, SMAD3 |
3.08504 |
[BP] GO:0045429 |
positive regulation of nitric oxide biosynthetic process
|
EGFR, INSR, PTGS2, SMAD3 |
3.08504 |
[BP] GO:2000379 |
positive regulation of reactive oxygen species metabolic process
|
EGFR, INSR, PTGS2, SMAD3, XDH |
3.03973 |
[BP] GO:0032268 |
regulation of cellular protein metabolic process
|
ADORA1, ALOX15, CSNK2A1, DUSP3, EGFR, ESR1, FABP4, FLT3, HSPA1A, HTR2C, IGF1R, INSR, KDR, MMP9, NUAK1, PIK3CA, PIK3CB, PTGS2, SMAD3, SRC, TEK, XDH |
3.02132 |
[BP] GO:0051701 |
interaction with host
|
EGFR, HSPA1A, INSR, MET, SMAD3, SRC |
3.01323 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, AKR1B1, ALOX15, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, ESR1, FABP3, FABP4, GPR35, HCAR2, HSPA1A, HTR2C, IGF1R, KDR, MET, MMP12, MMP9, PIK3CA, PPARA, PPARD, PTGS2, SMAD3, SRC, TEK, XDH |
3.00777 |
[BP] GO:0043405 |
regulation of MAP kinase activity
|
ADORA1, DUSP3, EGFR, FLT3, IGF1R, INSR, PIK3CB, SRC |
3.00382 |
[BP] GO:0002791 |
None
|
ACHE, ADORA1, CNR1, EGFR, HCAR2, HTR2C, MMP12, PPARD, SRC |
2.99783 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, ESR1, FABP3, FABP4, GPR35, HSPA1A, HTR2C, IGF1R, KDR, MET, MMP12, MMP9, PIK3CA, PPARA, PPARD, PTGS2, SMAD3, SRC, TEK, XDH |
2.99722 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, CA2, CYP1A1, EGFR, HSPA1A, MMP2, PPARA, PPARD, PTGS2, SMAD3, SRC, TEK |
2.99722 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.99722 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, CYP1B1, EGFR, HSPA1A, MMP9, PTGS1, PTGS2, SRC |
2.9861 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, ALOX15, CSNK2A1, EGFR, ESR1, FLT3, HSPA1A, HTR2C, IGF1R, INSR, KDR, MET, MMP12, MMP9, PIK3CA, PIK3CB, PPARA, PPARD, PTGS2, SMAD3, SRC, TEK, XDH |
2.98412 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, FABP3, IGF1R, INSR, PPARA, PTGS2, SRC, TEK |
2.9383 |
[BP] GO:0002682 |
regulation of immune system process
|
ADORA1, ALOX15, CA2, CNR1, CNR2, CYP19A1, DUSP3, ESR1, HCAR2, HSPA1A, MMP12, MMP2, PIK3CA, PIK3CB, SMAD3, SRC |
2.9383 |
[BP] GO:0050900 |
leukocyte migration
|
CNR2, FUT7, MMP1, MMP9, PIK3CA, PIK3CB, SRC, TEK |
2.92331 |
[BP] GO:0014066 |
regulation of phosphatidylinositol 3-kinase signaling
|
EGFR, FLT3, KDR, PPARD, TEK |
2.91466 |
[BP] GO:0002793 |
None
|
ACHE, ADORA1, EGFR, HCAR2, MMP12, PPARD, SRC |
2.88167 |
[BP] GO:2000377 |
regulation of reactive oxygen species metabolic process
|
CYP1B1, EGFR, INSR, PTGS2, SMAD3, XDH |
2.87707 |
[BP] GO:0001525 |
angiogenesis
|
CYP1B1, KDR, MMP2, PIK3CA, PIK3CB, PTGS2, TEK |
2.87448 |
[BP] GO:0019637 |
organophosphate metabolic process
|
ACHE, ALOX15, CSNK2A1, EGFR, HSPA1A, HTR2C, MET, PIK3CA, PIK3CB, PPARD, PTGS2, XDH |
2.83897 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ADORA1, ALOX15, EGFR, FLT3, HTR2C, INSR, KDR, MMP9, PIK3CA, PIK3CB, PTGS2, SRC, TEK, XDH |
2.83897 |
[BP] GO:0007213 |
None
|
CHRM1, CHRM2, CHRM4 |
2.83897 |
[BP] GO:0051222 |
positive regulation of protein transport
|
ACHE, CHRM1, EGFR, HCAR2, MMP12, PPARD, PTGS2, SMAD3, SRC |
2.81768 |
[BP] GO:0046883 |
regulation of hormone secretion
|
ADORA1, CNR1, CYP19A1, EGFR, HCAR2, HTR2C, PPARD |
2.81006 |
[BP] GO:0001952 |
regulation of cell-matrix adhesion
|
KDR, PIK3CB, SMAD3, SRC, TEK |
2.80662 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
ADORA1, ADORA3, CA1, CHRM4, CSNK2A1, EGFR, FLT3, GPR35, IGF1R, INSR, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, SMAD3, SRC, TEK |
2.7895 |
[BP] GO:0044089 |
positive regulation of cellular component biogenesis
|
ALOX15, ESR1, HSPA1A, KDR, MET, MMP1, SMAD3, SRC, TEK |
2.7895 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, ALOX15, EGFR, ESR1, FABP3, FLT3, HSPA1A, HTR2C, IGF1R, INSR, KDR, MET, MMP12, MMP9, PIK3CA, PIK3CB, PPARA, PPARD, PTGS2, SMAD3, SRC, TEK, XDH |
2.74788 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4, PPARD |
2.74756 |
[BP] GO:0006721 |
terpenoid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, EGFR, PPARD |
2.74048 |
[BP] GO:1903428 |
positive regulation of reactive oxygen species biosynthetic process
|
EGFR, INSR, PTGS2, SMAD3 |
2.74048 |
[BP] GO:0050994 |
None
|
ADORA1, CNR1, HCAR2, PPARA |
2.74048 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, CYP1B1, EGFR, MMP9, SRC |
2.72485 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, ALOX15, CSNK2A1, EGFR, ESR1, FLT3, HSPA1A, HTR2C, IGF1R, INSR, KDR, MET, MMP12, MMP9, PIK3CA, PIK3CB, PPARA, PPARD, PTGS2, SMAD3, SRC, TEK, XDH |
2.72268 |
[BP] GO:0070372 |
regulation of ERK1 and ERK2 cascade
|
ALOX15, DUSP3, EGFR, HTR2C, KDR, SRC, TEK |
2.71951 |
[BP] GO:0007187 |
None
|
ADORA1, CHRM1, CHRM2, CHRM4, CNR1, CNR2 |
2.71951 |
[BP] GO:0051047 |
None
|
ACHE, ADORA1, CYP19A1, EGFR, HCAR2, MMP12, PPARD, SRC |
2.70632 |
[BP] GO:0032496 |
response to lipopolysaccharide
|
CNR1, CNR2, CYP1A1, CYP1A2, PPARD, PTGS2, SRC |
2.69558 |
[BP] GO:0051893 |
regulation of focal adhesion assembly
|
KDR, SMAD3, SRC, TEK |
2.69244 |
[BP] GO:0090109 |
regulation of cell-substrate junction assembly
|
KDR, SMAD3, SRC, TEK |
2.69244 |
[BP] GO:0032102 |
negative regulation of response to external stimulus
|
ADORA1, CNR2, CYP19A1, PPARA, PPARD, SMAD3, TEK |
2.6841 |
[BP] GO:0032103 |
positive regulation of response to external stimulus
|
CNR1, EGFR, FABP4, KDR, MET, PTGS2, SMAD3 |
2.6841 |
[BP] GO:0010810 |
regulation of cell-substrate adhesion
|
ALOX15, KDR, PIK3CB, SMAD3, SRC, TEK |
2.66892 |
[BP] GO:0002009 |
morphogenesis of an epithelium
|
CA2, CA9, EGFR, ESR1, MET, SMAD3, SRC |
2.65941 |
[BP] GO:0001503 |
ossification
|
ALOX15, EGFR, MMP2, MMP9, TEK |
2.63715 |
[BP] GO:1904951 |
positive regulation of establishment of protein localization
|
ACHE, CHRM1, EGFR, HCAR2, MMP12, PPARD, PTGS2, SMAD3, SRC |
2.63313 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.63185 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
DUSP3, ESR1, HSPA1A, IGF1R, MET, MMP9, PTGS2, SRC, XDH |
2.62653 |
[BP] GO:1903391 |
regulation of adherens junction organization
|
KDR, SMAD3, SRC, TEK |
2.6238 |
[BP] GO:0045428 |
regulation of nitric oxide biosynthetic process
|
EGFR, INSR, PTGS2, SMAD3 |
2.6238 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, CYP1B1, EGFR, HSPA1A, MMP9, SRC |
2.61196 |
[BP] GO:0070374 |
positive regulation of ERK1 and ERK2 cascade
|
ALOX15, EGFR, HTR2C, KDR, SRC, TEK |
2.57618 |
[BP] GO:0051966 |
regulation of synaptic transmission, glutamatergic
|
ADORA1, CNR1, EGFR, PTGS2 |
2.57069 |
[BP] GO:0051246 |
regulation of protein metabolic process
|
ADORA1, ALOX15, CSNK2A1, DUSP3, EGFR, ESR1, FABP4, FLT3, HSPA1A, HTR2C, IGF1R, INSR, KDR, MMP9, NUAK1, PIK3CA, PIK3CB, PTGS2, SMAD3, SRC, TEK, XDH |
2.5705 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, ALOX15, CSNK2A1, EGFR, ESR1, FABP3, FLT3, HSPA1A, HTR2C, IGF1R, INSR, KDR, MET, MMP12, MMP9, PIK3CA, PIK3CB, PPARA, PPARD, PTGS2, SMAD3, SRC, TEK, XDH |
2.56263 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, CNR1, CNR2, CSNK2A1, DUSP3, EGFR, ESR1, FABP4, HCAR2, HSPA1A, IGF1R, KDR, MET, MMP12, MMP9, PIK3CA, PPARA, PPARD, PTGS2, SMAD3, SRC, XDH |
2.55583 |
[BP] GO:0006811 |
None
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, FABP3, HTR2C, PPARA, PPARD |
2.55583 |
[BP] GO:0002237 |
response to molecule of bacterial origin
|
CNR1, CNR2, CYP1A1, CYP1A2, PPARD, PTGS2, SRC |
2.55583 |
[BP] GO:0071498 |
cellular response to fluid shear stress
|
CA2, PTGS2, SRC |
2.54791 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, CA2, CA7, EGFR, PTGS2 |
2.54574 |
[BP] GO:0006644 |
phospholipid metabolic process
|
ACHE, ALOX15, CSNK2A1, EGFR, MET, PIK3CA, PIK3CB, PPARD |
2.54574 |
[BP] GO:0050801 |
ion homeostasis
|
CA12, CA2, CA7, EGFR, ESR1, FABP3, GPR35, HTR2C, PIK3CB, SMAD3 |
2.54466 |
[BP] GO:0097746 |
None
|
ADORA1, CHRM1, EGFR, PPARD, PTGS2 |
2.50143 |
[BP] GO:0035296 |
None
|
ADORA1, CHRM1, EGFR, PPARD, PTGS2 |
2.50143 |
[BP] GO:0050995 |
None
|
ADORA1, CNR1, HCAR2 |
2.49592 |
[BP] GO:0043281 |
regulation of cysteine-type endopeptidase activity involved in apoptotic process
|
CSNK2A1, MMP9, PTGS2, SMAD3, SRC, XDH |
2.49409 |
[BP] GO:0031349 |
positive regulation of defense response
|
CNR1, EGFR, FABP4, HSPA1A, MMP12, MMP2, PTGS2, SRC |
2.49076 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, EGFR, PPARD |
2.49076 |
[BP] GO:1903530 |
regulation of secretion by cell
|
ACHE, ADORA1, CNR1, CYP19A1, EGFR, HCAR2, HTR2C, MMP12, PPARD, SRC |
2.48707 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
AKR1B1, EGFR, ESR1, FLT3, IGF1R, INSR, MMP2, PTGS2, SMAD3, SRC |
2.4839 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, CA2, CA7, HTR2C, KDR, SRC |
2.47964 |
[BP] GO:0050805 |
negative regulation of synaptic transmission
|
ACHE, ADORA1, CNR2, PTGS2 |
2.46448 |
[BP] GO:0095500 |
None
|
CHRM1, CHRM2, CHRM4 |
2.45252 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.45252 |
[BP] GO:1903831 |
None
|
CHRM1, CHRM2, CHRM4 |
2.45252 |
[BP] GO:0030574 |
collagen catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.4452 |
[BP] GO:0006940 |
None
|
ADORA1, CHRM1, CHRM2, PTGS2 |
2.4452 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
ALOX15, CNR1, ESR1, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP9, SMAD3, SRC, TEK |
2.42702 |
[BP] GO:0014068 |
positive regulation of phosphatidylinositol 3-kinase signaling
|
FLT3, KDR, PPARD, TEK |
2.42481 |
[BP] GO:0010632 |
regulation of epithelial cell migration
|
KDR, MET, MMP9, PTGS2, SRC, TEK |
2.4161 |
[BP] GO:0043549 |
regulation of kinase activity
|
ADORA1, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, PIK3CA, PIK3CB, SRC, TEK |
2.4161 |
[BP] GO:0051894 |
None
|
KDR, SMAD3, TEK |
2.41123 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1 |
2.41123 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.41123 |
[BP] GO:0050880 |
None
|
ADORA1, CHRM1, EGFR, PPARD, PTGS2 |
2.40811 |
[BP] GO:0033031 |
positive regulation of neutrophil apoptotic process
|
HCAR2, PIK3CB |
2.40675 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
CA2, CA7 |
2.40675 |
[BP] GO:0038171 |
None
|
CNR1, CNR2 |
2.40675 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.40675 |
[BP] GO:0006954 |
inflammatory response
|
ADORA1, ADORA3, ALOX15, CNR2, PIK3CA, PIK3CB, PTGS1, PTGS2 |
2.40647 |
[BP] GO:0035150 |
None
|
ADORA1, CHRM1, EGFR, PPARD, PTGS2 |
2.4008 |
[BP] GO:0009888 |
tissue development
|
ALOX15, CYP1B1, INSR, KDR, PIK3CA, PPARA, PPARD, PTGS2, SMAD3 |
2.39868 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX15, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, PPARA, PPARD, PTGS1, PTGS2 |
2.38853 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, CHRM1, CSNK2A1, CYP1A1, CYP1A2, DUSP3, EGFR, ESR1, F10, FLT3, FUT7, HSPA1A, HTR2C, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIK3CA, PPARA, PPARD, PTGS2, SMAD3, SRC, TEK, XDH |
2.38853 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, EGFR, FABP3, KDR, MMP2, PTGS2, SRC |
2.38544 |
[BP] GO:0006928 |
movement of cell or subcellular component
|
CNR2, CYP1B1, EGFR, FUT7, KDR, MMP1, MMP12, MMP9, PIK3CA, PIK3CB, PPARD, PTGS2, SRC, TEK |
2.33482 |
[BP] GO:0031334 |
positive regulation of protein complex assembly
|
ALOX15, ESR1, HSPA1A, MET, MMP1, SRC |
2.3324 |
[BP] GO:1903393 |
None
|
KDR, SMAD3, TEK |
2.32631 |
[BP] GO:0050678 |
None
|
EGFR, KDR, MMP12, PPARD, SMAD3, TEK, XDH |
2.32522 |
[BP] GO:0048010 |
vascular endothelial growth factor receptor signaling pathway
|
KDR, PIK3CA, PIK3CB, SRC |
2.30795 |
[BP] GO:0043271 |
negative regulation of ion transport
|
ADORA1, CNR1, GPR35, MMP9, PTGS2 |
2.29511 |
[BP] GO:0044243 |
multicellular organismal catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.28713 |
[BP] GO:0007271 |
None
|
CHRM1, CHRM2, CHRM4 |
2.28414 |
[BP] GO:0006650 |
glycerophospholipid metabolic process
|
ACHE, ALOX15, CSNK2A1, EGFR, MET, PIK3CA, PIK3CB |
2.28414 |
[BP] GO:0051046 |
None
|
ACHE, ADORA1, CNR1, CYP19A1, EGFR, HCAR2, HTR2C, MMP12, PPARD, SRC |
2.27828 |
[BP] GO:0050714 |
None
|
ACHE, EGFR, HCAR2, MMP12, PPARD, SRC |
2.24274 |
[BP] GO:0046320 |
None
|
CNR1, FABP3, PPARA |
2.24232 |
[BP] GO:2000116 |
regulation of cysteine-type endopeptidase activity
|
CSNK2A1, MMP9, PTGS2, SMAD3, SRC, XDH |
2.23518 |
[BP] GO:0007193 |
None
|
ADORA1, CHRM1, CHRM2, CHRM4 |
2.23045 |
[BP] GO:0010631 |
epithelial cell migration
|
CYP1B1, KDR, PIK3CA, PPARD |
2.21085 |
[BP] GO:0006636 |
unsaturated fatty acid biosynthetic process
|
ALOX15, PTGS1, PTGS2 |
2.20227 |
[BP] GO:0043065 |
positive regulation of apoptotic process
|
CNR1, CYP1B1, HCAR2, MMP9, PIK3CB, PTGS2, SMAD3, SRC, XDH |
2.19248 |
[BP] GO:0048732 |
gland development
|
CSNK2A1, CYP19A1, EGFR, INSR, PIK3CA, SMAD3 |
2.18297 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA1, ADORA3, ALOX15, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, FABP3, FABP4, FLT3, HCAR2, HSPA1A, HTR2C, IGF1R, INSR, KDR, MET, MMP12, MMP9, NUAK1, PIK3CA, PIK3CB, PPARA, PPARD, PTGS2, SMAD3, SRC, TEK, XDH |
2.18255 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
CYP1A1, CYP1B1, EGFR, ESR1, FLT3, PTGS2, SRC |
2.18255 |
[BP] GO:0030258 |
lipid modification
|
CYP1A1, EGFR, MET, PIK3CA, PIK3CB, PPARD |
2.17694 |
[BP] GO:0022617 |
extracellular matrix disassembly
|
MMP1, MMP12, MMP2, MMP9 |
2.17628 |
[BP] GO:0043068 |
positive regulation of programmed cell death
|
CNR1, CYP1B1, HCAR2, MMP9, PIK3CB, PTGS2, SMAD3, SRC, XDH |
2.16879 |
[BP] GO:0043552 |
positive regulation of phosphatidylinositol 3-kinase activity
|
FLT3, SRC, TEK |
2.16879 |
[BP] GO:0042743 |
hydrogen peroxide metabolic process
|
CYP1A1, CYP1A2, EGFR |
2.16879 |
[BP] GO:0010638 |
positive regulation of organelle organization
|
ALOX15, HSPA1A, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
2.16195 |
[BP] GO:0048729 |
tissue morphogenesis
|
CA2, CA9, EGFR, ESR1, MET, SMAD3, SRC |
2.16195 |
[BP] GO:1903532 |
None
|
ACHE, CYP19A1, EGFR, HCAR2, MMP12, PPARD, SRC |
2.1556 |
[BP] GO:0032963 |
collagen metabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.14391 |
[BP] GO:1901890 |
None
|
KDR, SMAD3, TEK |
2.13536 |
[BP] GO:0071276 |
cellular response to cadmium ion
|
CYP1A2, EGFR, MMP9 |
2.13536 |
[BP] GO:0014065 |
phosphatidylinositol 3-kinase signaling
|
IGF1R, PIK3CA, PIK3CB |
2.13536 |
[BP] GO:0050673 |
epithelial cell proliferation
|
ESR1, PIK3CB, PPARD, TEK |
2.13321 |
[BP] GO:0033273 |
response to vitamin
|
CYP1A1, EGFR, PPARD, PTGS2 |
2.13321 |
[BP] GO:1903426 |
None
|
EGFR, INSR, PTGS2, SMAD3 |
2.13321 |
[BP] GO:1901888 |
regulation of cell junction assembly
|
KDR, SMAD3, SRC, TEK |
2.13321 |
[BP] GO:0050794 |
regulation of cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, ALOX15, CA1, CA2, CA7, CA9, CHRM1, CHRM2, CHRM4, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DUSP3, EGFR, ESR1, F10, FABP3, FABP4, FLT3, GPR35, HCAR2, HSPA1A, HTR2C, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIK3CA, PIK3CB, PPARA, PPARD, PTGS1, PTGS2, SMAD3, SRC, TEK, XDH |
2.13321 |
[BP] GO:0007188 |
None
|
ADORA1, CHRM1, CHRM2, CHRM4, CNR1 |
2.13321 |
[BP] GO:0006468 |
protein phosphorylation
|
CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, SRC, TEK |
2.11121 |
[BP] GO:0019217 |
None
|
CNR1, FABP3, PPARA, PTGS2 |
2.09582 |
[BP] GO:0051223 |
None
|
ACHE, CHRM1, CNR1, EGFR, HCAR2, MMP12, PPARD, PTGS2, SMAD3, SRC |
2.0903 |
[BP] GO:0001505 |
regulation of neurotransmitter levels
|
ACHE, CYP1B1, EGFR, INSR, PTGS2, SMAD3 |
2.0903 |
[BP] GO:0090407 |
organophosphate biosynthetic process
|
ACHE, ALOX15, CSNK2A1, HTR2C, PIK3CA, PIK3CB, PPARD, PTGS2 |
2.0903 |
[BP] GO:0010595 |
positive regulation of endothelial cell migration
|
KDR, MET, PTGS2, TEK |
2.08395 |
[BP] GO:0033029 |
regulation of neutrophil apoptotic process
|
HCAR2, PIK3CB |
2.08395 |
[BP] GO:0032229 |
None
|
ADORA1, CNR2 |
2.08395 |
[BP] GO:0043436 |
oxoacid metabolic process
|
ALOX15, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, PPARA, PPARD, PTGS1, PTGS2 |
2.07559 |
[BP] GO:0090218 |
positive regulation of lipid kinase activity
|
FLT3, SRC, TEK |
2.07559 |
[BP] GO:1902893 |
None
|
PPARA, PPARD, SMAD3 |
2.07559 |
[BP] GO:0010907 |
None
|
INSR, PPARA, SRC |
2.07559 |
[BP] GO:0022900 |
electron transport chain
|
AKR1B1, CYP19A1, CYP1A2, NQO2, XDH |
2.07276 |
[BP] GO:0045859 |
regulation of protein kinase activity
|
ADORA1, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, PIK3CA, PIK3CB, SRC |
2.07251 |
[BP] GO:0044259 |
multicellular organismal macromolecule metabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.07251 |
[BP] GO:0008654 |
phospholipid biosynthetic process
|
ACHE, ALOX15, CSNK2A1, PIK3CA, PIK3CB, PPARD |
2.05848 |
[BP] GO:0098771 |
inorganic ion homeostasis
|
CA12, CA2, CA7, EGFR, ESR1, GPR35, HTR2C, PIK3CB, SMAD3 |
2.05694 |
[BP] GO:0065007 |
biological regulation
|
ACHE, ADORA1, ADORA3, AKR1B1, ALOX15, CA1, CA12, CA2, CA7, CA9, CHRM1, CHRM2, CHRM4, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, F10, FABP3, FABP4, FLT3, GPR35, HCAR2, HSD17B1, HSPA1A, HTR2C, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIK3CA, PIK3CB, PPARA, PPARD, PTGS1, PTGS2, SMAD3, SRC, TEK, XDH |
2.05599 |
[BP] GO:0071900 |
regulation of protein serine/threonine kinase activity
|
ADORA1, DUSP3, EGFR, FLT3, IGF1R, INSR, PIK3CB, SRC |
2.05386 |
[BP] GO:0043406 |
positive regulation of MAP kinase activity
|
ADORA1, EGFR, FLT3, INSR, PIK3CB, SRC |
2.02814 |
[BP] GO:0006082 |
organic acid metabolic process
|
ALOX15, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, PPARA, PPARD, PTGS1, PTGS2 |
2.02068 |
[BP] GO:0043154 |
negative regulation of cysteine-type endopeptidase activity involved in apoptotic process
|
CSNK2A1, MMP9, PTGS2, SRC |
2.00522 |
[CC] GO:0005886 |
plasma membrane
|
ACHE, ADORA1, ADORA3, ALOX15, CA12, CA14, CA2, CA4, CA9, CHRM1, CHRM2, CHRM4, CNR1, CNR2, CSNK2A1, EGFR, ESR1, F10, FLT3, GPR35, HCAR2, HTR2C, IGF1R, INSR, KDR, MET, MMP2, PIK3CA, PIK3CB, SMAD3, SRC, TEK |
4.1488 |
[CC] GO:0044459 |
plasma membrane part
|
ADORA1, ADORA3, ALOX15, CA2, CA4, CA9, CHRM1, CHRM2, CHRM4, CNR1, CNR2, DUSP3, EGFR, F10, FLT3, GPR35, HTR2C, IGF1R, INSR, KDR, MET, PTGS2, SRC, TEK |
4.10464 |
[CC] GO:0098590 |
plasma membrane region
|
ADORA1, CA2, CA4, CA9, CHRM1, CHRM2, CHRM4, CNR1, EGFR, INSR, MET, PTGS2, SRC, TEK |
3.74081 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA1, ADORA3, CA4, CHRM1, CHRM2, CHRM4, CNR1, CNR2, F10, FLT3, GPR35, HTR2C, IGF1R, INSR, KDR, MET, TEK |
3.71122 |
[CC] GO:0044425 |
membrane part
|
ACHE, ADORA1, ADORA3, ALOX15, CA12, CA14, CA2, CA4, CA9, CHRM1, CHRM2, CHRM4, CNR1, CNR2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DUSP3, EGFR, ESR1, F10, FLT3, FUT7, GPR35, HCAR2, HTR2C, IGF1R, INSR, KDR, MET, PIK3CA, PIK3CB, PTGS1, PTGS2, SRC, TEK |
3.63697 |
[CC] GO:0016020 |
membrane
|
ACHE, ADORA1, ADORA3, ALOX15, CA12, CA14, CA2, CA4, CA9, CHRM1, CHRM2, CHRM4, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EGFR, ESR1, F10, FLT3, FUT7, GPR35, HCAR2, HTR2C, IGF1R, INSR, KDR, MET, MMP2, PIK3CA, PIK3CB, PTGS1, PTGS2, SMAD3, SRC, TEK |
2.84646 |
[CC] GO:0005887 |
integral component of plasma membrane
|
ADORA1, ADORA3, CHRM1, CHRM2, CHRM4, CNR1, CNR2, FLT3, GPR35, HTR2C, IGF1R, INSR, KDR, MET, TEK |
2.76151 |
[CC] GO:0016323 |
basolateral plasma membrane
|
ADORA1, CA2, CA4, CA9, EGFR, TEK |
2.69001 |
[CC] GO:0045121 |
membrane raft
|
CNR1, EGFR, INSR, KDR, PTGS2, SRC, TEK |
2.57294 |
[CC] GO:0098857 |
membrane microdomain
|
CNR1, EGFR, INSR, KDR, PTGS2, SRC, TEK |
2.56048 |
[CC] GO:0098589 |
membrane region
|
CNR1, EGFR, INSR, KDR, PTGS2, SRC, TEK |
2.16708 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
17.6107 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX15, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, ESR1, MMP1, MMP12, MMP2, MMP9, NQO2, PPARA, PPARD, SMAD3, XDH |
12.6943 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
11.2652 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX15, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EGFR, ESR1, F10, FABP3, FABP4, FLT3, HSD17B1, HSPA1A, HTR2C, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NQO2, NUAK1, PIK3CA, PIK3CB, PPARA, PPARD, PTGS1, PTGS2, SMAD3, SRC, TEK, XDH |
10.2955 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
10.2312 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, ADORA1, AKR1B1, ALOX15, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CHRM1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DUSP3, EGFR, F10, FLT3, FUT7, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP12, MMP2, MMP9, NQO2, NUAK1, PIK3CA, PIK3CB, PTGS1, PTGS2, SRC, TEK, XDH |
9.3401 |
[MF] GO:0008144 |
drug binding
|
ACHE, CHRM1, CHRM2, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, EGFR, FLT3, HSPA1A, HTR2C, IGF1R, INSR, KDR, MET, NQO2, NUAK1, PIK3CA, PIK3CB, PPARA, PPARD, SRC, TEK |
8.62959 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, ESR1, MMP1, MMP12, MMP2, MMP9, NQO2, PPARA, PPARD, SMAD3 |
7.65998 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
6.95615 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, PTGS1, PTGS2, SRC |
6.84144 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
6.81281 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, PTGS1, PTGS2, SRC |
6.62325 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK |
6.34146 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, CHRM1, CHRM2, CHRM4, CNR1, CNR2, EGFR, ESR1, FLT3, GPR35, HCAR2, HTR2C, IGF1R, INSR, KDR, MET, PPARA, PPARD, TEK |
5.9354 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK |
5.73106 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13 |
5.52994 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, CHRM1, CHRM2, CHRM4, CNR1, CNR2, EGFR, ESR1, FLT3, GPR35, HCAR2, HTR2C, IGF1R, INSR, KDR, MET, PPARA, PPARD, SMAD3, TEK |
5.22828 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX15, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, ESR1, F10, HTR2C, MMP1, MMP12, MMP2, MMP9, NQO2, NUAK1, PPARA, PPARD, PTGS1, PTGS2, SMAD3, XDH |
5.20842 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, CHRM1, CHRM2, CHRM4, CNR1, CNR2, EGFR, ESR1, FLT3, GPR35, HCAR2, HTR2C, IGF1R, INSR, KDR, MET, PPARA, PPARD, TEK |
5.20842 |
[MF] GO:0048037 |
cofactor binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, HSD17B1, NQO2, PTGS1, PTGS2, SRC, XDH |
5.16397 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, PTGS1, PTGS2 |
5.15952 |
[MF] GO:0043560 |
insulin receptor substrate binding
|
IGF1R, INSR, PIK3CA, PIK3CB |
5.14489 |
[MF] GO:0005506 |
iron ion binding
|
ALOX15, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, XDH |
5.07791 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, CHRM1, CHRM2, CHRM4, CNR1, CNR2, EGFR, ESR1, FLT3, GPR35, HCAR2, HTR2C, IGF1R, INSR, KDR, MET, PPARA, PPARD, TEK |
5.05072 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
4.719 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA1, ADORA3, CHRM1, CHRM2, CHRM4, CNR1, CNR2, EGFR, FLT3, GPR35, HCAR2, HTR2C, IGF1R, INSR, KDR, MET, TEK |
4.50685 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA1, ADORA3, CHRM1, CHRM2, CHRM4, CNR1, CNR2, EGFR, FLT3, GPR35, HCAR2, HTR2C, IGF1R, INSR, KDR, MET, TEK |
4.50685 |
[MF] GO:0046872 |
metal ion binding
|
ALOX15, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, ESR1, F10, MMP1, MMP12, MMP2, MMP9, NQO2, NUAK1, PPARA, PPARD, PTGS1, PTGS2, SMAD3, XDH |
4.39785 |
[MF] GO:0042562 |
hormone binding
|
ACHE, EGFR, HSD17B1, IGF1R, INSR, NQO2 |
4.34462 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13 |
4.32609 |
[MF] GO:0016907 |
None
|
CHRM1, CHRM2, CHRM4 |
4.31643 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, ALOX15, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, HSD17B1, NQO2, PTGS1, PTGS2, XDH |
4.31203 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
4.11703 |
[MF] GO:0004716 |
signal transducer, downstream of receptor, with protein tyrosine kinase activity
|
EGFR, INSR, KDR |
3.52934 |
[MF] GO:0008395 |
steroid hydroxylase activity
|
CYP19A1, CYP1A1, CYP2A13, CYP2A6 |
3.36603 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIK3CB, SRC, TEK |
3.30519 |
[MF] GO:0004672 |
protein kinase activity
|
CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, SRC, TEK |
3.28097 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADORA1, EGFR, FLT3, IGF1R, INSR, KDR, MMP12, MMP9, PPARA, SMAD3, SRC |
3.25913 |
[MF] GO:0099528 |
None
|
CHRM1, CHRM2, CHRM4, HTR2C |
3.19785 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MMP12, MMP9, PPARA, SMAD3, SRC |
3.05045 |
[MF] GO:0004666 |
prostaglandin-endoperoxide synthase activity
|
PTGS1, PTGS2 |
3.01323 |
[MF] GO:0008389 |
None
|
CYP2A13, CYP2A6 |
3.01323 |
[MF] GO:0016301 |
kinase activity
|
CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIK3CB, SRC, TEK |
2.9748 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, CYP19A1, CYP1A2, NQO2, XDH |
2.72485 |
[MF] GO:0015464 |
None
|
CHRM1, CHRM2, CHRM4 |
2.70797 |
[MF] GO:0036094 |
small molecule binding
|
ADORA1, CSNK2A1, EGFR, FABP3, FABP4, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NQO2, NUAK1, PIK3CA, PIK3CB, PPARD, SRC, TEK, XDH |
2.65941 |
[MF] GO:0050473 |
arachidonate 15-lipoxygenase activity
|
ALOX15, PTGS2 |
2.63185 |
[MF] GO:0004949 |
None
|
CNR1, CNR2 |
2.63185 |
[MF] GO:0008227 |
None
|
CHRM1, CHRM2, CHRM4, HTR2C |
2.6238 |
[MF] GO:0043168 |
anion binding
|
ALOX15, CSNK2A1, EGFR, F10, FABP3, FABP4, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NQO2, NUAK1, PIK3CA, PIK3CB, PPARD, SRC, TEK, XDH |
2.5147 |
[MF] GO:0005518 |
collagen binding
|
ACHE, MMP12, MMP9, SMAD3 |
2.48707 |
[MF] GO:0019838 |
growth factor binding
|
EGFR, IGF1R, INSR, KDR, TEK |
2.42698 |
[MF] GO:0046934 |
phosphatidylinositol-4,5-bisphosphate 3-kinase activity
|
EGFR, MET, PIK3CA, PIK3CB |
2.42481 |
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIK3CB, SRC, TEK |
2.40946 |
[MF] GO:0052813 |
phosphatidylinositol bisphosphate kinase activity
|
EGFR, MET, PIK3CA, PIK3CB |
2.37381 |
[MF] GO:0005504 |
None
|
FABP3, FABP4, PPARD |
2.28414 |
[MF] GO:0035004 |
phosphatidylinositol 3-kinase activity
|
EGFR, MET, PIK3CA, PIK3CB |
2.27055 |
[MF] GO:0043559 |
insulin binding
|
IGF1R, INSR |
2.21766 |
[MF] GO:0004064 |
arylesterase activity
|
CA1, CA2 |
2.08395 |
[MF] GO:0035258 |
None
|
ESR1, FLT3, SMAD3, SRC |
2.03955 |